We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Herzuma

News List

FDA clears Celltrion, Teva's biosimilar version of Roche's Herceptin firstwordpharma
December 17, 2018
Celltrion and Teva announced that the FDA has approved Herzuma (trastuzumab-pkrb), a biosimilar referencing Roche's Herceptin (trastuzumab), for the treatment of certain patients with HER2-overexpressing breast cancer. Specifically, Herzuma was cleared fo
FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin drugs
December 17, 2018
Celltrion, Inc. and Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Herzuma (trastuzumab-pkrb).....
Herceptin biosimilar Herzuma launched in Europe pharmatimes
May 07, 2018
Mundipharma said its network of companies has kicked off the rollout of Celltrion’s Herceptin biosimilar Herzuma in Europe.